“Humanitarian Trials” Not Welcomed but Well-Designed: JPMA Regulatory Chief

JPMA Regulatory Affairs Committee Chairman Masaaki Kuwahara The Japan Pharmaceutical Manufacturers Association (JPMA) does not welcome “humanitarian trials,” but a basic plan endorsed by a health ministry panel earlier this month deserves certain credit for incorporating some of the requests...read more